speaker for Galderma and Allergan. Dr LaTowsky is an investigator for Galderma, AbbVie, Arcutis Biotherapeutics, Arena Pharmaceuticals, Brickell Biotech, ChemoCentryx, Eli Lilly, Pulse Biosciences, Soliton, Allergan, TARGET PharmaSolutions, Kiniksa Pharmaceuticals, Corrona, Teres Bio, Endo; a consultant for Pulse Biosciences and Soliton; and an advisory board member for Galderma, Endo, Allergan, the AAD, and Castle Biosciences. Dr Prather is an investigator for Galderma; and a trainer for Galderma, Allergan, and Merz.
Galderma funded the study and provided medical writing support.
Disclaimer: Previously presented as poster at the American Society for Dermatologic Surgery (ASDS), October 2020, ODAC Jan 2021, Winter Clinical January 2021, and Maui Derm January 2021.
Galderma funded the study and provided medical writing support.
Disclaimer: Previously presented as poster at the American Society for Dermatologic Surgery (ASDS), October 2020, ODAC Jan 2021, Winter Clinical January 2021, and Maui Derm January 2021.
REFERENCES
1. Sculptra Aesthetic Instructions for Use http://www.galdermausa.com/IFU/ Sculptra_Aesthetic_IFU.pdf
2. Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol. 2004;3(5):542-547.
3. Palm M, Chayavichitsilp P. The "skinny"on Sculptra: a practical primer to volumization with poly-L-lactic acid. J Drugs Dermatol. 2012;11(9):1046-1052.
4. Narins RS, Baumann L, Brandt FS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 2010;62(3):448-462.
5. Brown SA, Rohrich RJ, Baumann L, et al. Subject global evaluation and subject satisfaction using injectable poly-L-lactic acid versus human collagen for the correction of nasolabial fold wrinkles. Plast Reconstruct Surg. 2011;127(4):1684-1692.
6. Brandt FS, Cazzaniga A, Baumann L, et al. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles. Aesthet Surg J. 2011;31(5):521-528.
7. Palm M, Mayoral F, Rajani A, et al. Chart review presenting safety of injectable PLLA used with alternative reconstitution volume for facial treatments. J Drugs Dermatol. 2021;20(1):118-122.
8. Alessio R, Rzany B, Eve L, et al. European expert recommendations on the use of injectable poly-L-lactic acid for facial rejuvenation. J Drugs Dermatol. 2014;13(9):1057-1066.
9. Vleggaar D, Fitzgerald R, Lorenc ZP, et al. Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization. J Drugs Dermatol. 2014;13(4 Suppl):s44-51.
10. Baumann K, Alm J, Norberg M, Ejehorn M. Immediate use after reconstitution of a biostimulatory poly-l-lactic acid injectable implant. J Drugs Dermatol. 2020;19(12):1199-1203.
11. Lemperle G, Holmes RE, Cohen SR, Lemperle SM. A classification of facial wrinkles. Plast Reconstruct Surg. 2001;108(6):1735-1750; discussion 1751- 1732.
12. Rossner F, Rossner M, Hartmann V, Erdmann R, Wiest LG, Rzany B. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: 8-year results from the Injectable Filler Safety study. J Cosmet Dermatol. 2009;8(1):14-18.
13. Lorenc ZP, Greene T, Gottschalk RW. Injectable poly-l-lactic acid: understanding its use in the current era. J Drugs Dermatol. 2016;15(6): 759-762
2. Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol. 2004;3(5):542-547.
3. Palm M, Chayavichitsilp P. The "skinny"on Sculptra: a practical primer to volumization with poly-L-lactic acid. J Drugs Dermatol. 2012;11(9):1046-1052.
4. Narins RS, Baumann L, Brandt FS, et al. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 2010;62(3):448-462.
5. Brown SA, Rohrich RJ, Baumann L, et al. Subject global evaluation and subject satisfaction using injectable poly-L-lactic acid versus human collagen for the correction of nasolabial fold wrinkles. Plast Reconstruct Surg. 2011;127(4):1684-1692.
6. Brandt FS, Cazzaniga A, Baumann L, et al. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles. Aesthet Surg J. 2011;31(5):521-528.
7. Palm M, Mayoral F, Rajani A, et al. Chart review presenting safety of injectable PLLA used with alternative reconstitution volume for facial treatments. J Drugs Dermatol. 2021;20(1):118-122.
8. Alessio R, Rzany B, Eve L, et al. European expert recommendations on the use of injectable poly-L-lactic acid for facial rejuvenation. J Drugs Dermatol. 2014;13(9):1057-1066.
9. Vleggaar D, Fitzgerald R, Lorenc ZP, et al. Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization. J Drugs Dermatol. 2014;13(4 Suppl):s44-51.
10. Baumann K, Alm J, Norberg M, Ejehorn M. Immediate use after reconstitution of a biostimulatory poly-l-lactic acid injectable implant. J Drugs Dermatol. 2020;19(12):1199-1203.
11. Lemperle G, Holmes RE, Cohen SR, Lemperle SM. A classification of facial wrinkles. Plast Reconstruct Surg. 2001;108(6):1735-1750; discussion 1751- 1732.
12. Rossner F, Rossner M, Hartmann V, Erdmann R, Wiest LG, Rzany B. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: 8-year results from the Injectable Filler Safety study. J Cosmet Dermatol. 2009;8(1):14-18.
13. Lorenc ZP, Greene T, Gottschalk RW. Injectable poly-l-lactic acid: understanding its use in the current era. J Drugs Dermatol. 2016;15(6): 759-762
AUTHOR CORRESPONDENCE
Melanie Palm MD MBA drpalm@artofskinmd.com
